semaglutide patent india Novo Nordisk expiry opens door to cheaper weight-loss drugs in India Obesity Crisis: The Expiry

Abstract Glucagon-like peptide (GLP)-1 receptor agonists are the cornerstone in the treatment of hyperglycemia in many people suffering from type 2 diabetes (T2D)

It evaluated the comparative effectiveness and safety of Zepbound and Wegovy over a 52-week treatment period

The Case for Tirzepatide Tirzepatide (combined with glycine for enhanced tolerability and metabolic benefits) is our primary prescription option for weight loss

doi: 10.1111/dom.12958 343 PearsonMJUngerRHHollandWL

Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should discuss this with their prescriber as a precaution

Semaglutide can be used in patients with a history of breast cancer who are taking tamoxifen, but it should be prescribed with caution